Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA clears antimetastatic carbohydrate compound for human trials

Jan. 15, 1997

AEterna accelerates anticancer clinical program

Jan. 15, 1997

New MDR modulators disclosed by Vertex

Jan. 15, 1997

Potent antitumor agents described by Daiichi

Jan. 15, 1997

Amgen discloses novel eck receptor ligands

Jan. 14, 1997

Kao discloses cell adhesion inhibitors

Jan. 14, 1997

Thomas Jefferson University claims new apoptotic cysteine protease

Jan. 14, 1997

TLC ELL-12 in toxicology testing

Jan. 13, 1997

Cell Genesys signs cancer gene therapy R&D collaborations

Jan. 13, 1997

Chemopreventive properties of resveratrol publicized

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...